Literature DB >> 24306065

Effects of chemotherapy on the parotid and submandibular glands in head and neck cancer patients treated with chemoradiotherapy.

A A M van der Veldt1, E F Smit, E F I Comans, A A Lammertsma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24306065     DOI： 10.1007/s00066-013-0487-y

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  7 in total

1.  The effect of concomitant chemotherapy on parotid gland function following head and neck IMRT.

Authors:  Aisha B Miah; Sarah L Gulliford; Shreerang A Bhide; Shane H Zaidi; Kate L Newbold; Kevin J Harrington; Christopher M Nutting
Journal:  Radiother Oncol       Date:  2013-03-26       Impact factor: 6.280

2.  Diffusion-weighted MR imaging of salivary glands with gustatory stimulation: comparison before and after radiotherapy.

Authors:  Yunyan Zhang; Dan Ou; Yajia Gu; Xiayun He; Weijun Peng; Jian Mao; Lei Yue; Xigang Shen
Journal:  Acta Radiol       Date:  2013-07-01       Impact factor: 1.990

3.  Taxane-containing induction chemotherapy followed by definitive chemoradiotherapy. Outcome in patients with locally advanced head and neck cancer.

Authors:  J O Brömme; M Schmücking; A Arnold; R Giger; D Rauch; D Leiser; L Plasswilm; A Geretschläger; P Ghadjar; D M Aebersold
Journal:  Strahlenther Onkol       Date:  2013-07-04       Impact factor: 3.621

4.  Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.

Authors:  Christopher M Nutting; James P Morden; Kevin J Harrington; Teresa Guerrero Urbano; Shreerang A Bhide; Catharine Clark; Elizabeth A Miles; Aisha B Miah; Kate Newbold; MaryAnne Tanay; Fawzi Adab; Sarah J Jefferies; Christopher Scrase; Beng K Yap; Roger P A'Hern; Mark A Sydenham; Marie Emson; Emma Hall
Journal:  Lancet Oncol       Date:  2011-01-12       Impact factor: 41.316

Review 5.  Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management.

Authors:  Mark S Chambers; Adam S Garden; Merrill S Kies; Jack W Martin
Journal:  Head Neck       Date:  2004-09       Impact factor: 3.147

6.  Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.

Authors:  Jan B Vermorken; Eva Remenar; Carla van Herpen; Thierry Gorlia; Ricard Mesia; Marian Degardin; John S Stewart; Svetislav Jelic; Jan Betka; Joachim H Preiss; Danielle van den Weyngaert; Ahmad Awada; Didier Cupissol; Heinz R Kienzer; Augustin Rey; Isabelle Desaunois; Jacques Bernier; Jean-Louis Lefebvre
Journal:  N Engl J Med       Date:  2007-10-25       Impact factor: 91.245

7.  Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.

Authors:  Marshall R Posner; Diane M Hershock; Cesar R Blajman; Elizabeth Mickiewicz; Eric Winquist; Vera Gorbounova; Sergei Tjulandin; Dong M Shin; Kevin Cullen; Thomas J Ervin; Barbara A Murphy; Luis E Raez; Roger B Cohen; Monica Spaulding; Roy B Tishler; Berta Roth; Rosana del Carmen Viroglio; Varagur Venkatesan; Ilya Romanov; Sanjiv Agarwala; K William Harter; Matthew Dugan; Anthony Cmelak; Arnold M Markoe; Paul W Read; Lynn Steinbrenner; A Dimitrios Colevas; Charles M Norris; Robert I Haddad
Journal:  N Engl J Med       Date:  2007-10-25       Impact factor: 91.245
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.